Literature DB >> 22899005

Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

G Silvestri1, M A Williams, C McAuley, K Oakes, E Sillery, D C Henderson, S Ferguson, V Silvestri, K A Muldrew.   

Abstract

AIMS AND
PURPOSE: The aim of this study was to describe the prevalence and characteristics of drusen and pigmentary changes in a middle-aged population.
METHODS: Retinal images from 500 individuals aged 18-54 years were included. The source of participants was two UK optometry practices. Retinal images were graded using the Wisconsin Age-Related Maculopathy Grading System. However, owing to the relatively young age of the population studied, a new category of drusen of smaller size (<31.5 μm) was introduced.
RESULTS: Drusen were identified within the central macular grid in 91.48% of all gradable eyes and in 444 subjects. Drusen sized <31.5 μm were present in 89.7% of eyes, drusen sized >31.5 μm and <63 μm were present in 45.9% of all eyes and drusen >63 μm and <125 μm were present in only 1.7% of eyes. No eye had drusen larger or equal to 125 μm. Very few eyes (1.2%) showed pigmentary changes within the grid. Drusen load increased with increasing age, P <0.001.
CONCLUSIONS: The frequency of drusen in a younger Caucasian population aged 18-54 years is high, with 91.48% of all gradable eyes having drusen. The most frequent drusen subtype was hard distinct drusen <31.5 μm. No druse greater or equal in size to 125 μm was seen. Pigmentary changes are rare.

Entities:  

Mesh:

Year:  2012        PMID: 22899005      PMCID: PMC3470061          DOI: 10.1038/eye.2012.165

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  34 in total

1.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study.

Authors:  S H Sarks; J J Arnold; M C Killingsworth; J P Sarks
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

2.  The challenges and surprises of studying the genetics of age-related macular degeneration.

Authors:  Elias I Traboulsi
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

3.  The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy.

Authors:  K J Cruickshanks; R F Hamman; R Klein; D M Nondahl; S M Shetterly
Journal:  Arch Ophthalmol       Date:  1997-02

4.  Seven year follow-up of age-related maculopathy in an elderly British population.

Authors:  J M Sparrow; A J Dickinson; A M Duke; J R Thompson; J M Gibson; A R Rosenthal
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  Prevalence of age-related maculopathy at two points in time in an elderly British population.

Authors:  A J Dickinson; J M Sparrow; A M Duke; J R Thompson; J M Gibson; A R Rosenthal
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

6.  Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey.

Authors:  D S Friedman; J Katz; N M Bressler; B Rahmani; J M Tielsch
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

7.  Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER.

Authors:  Beatriz Muñoz; Ronald Klein; Jorge Rodriguez; Robert Snyder; Sheila K West
Journal:  Arch Ophthalmol       Date:  2005-11

8.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

9.  14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study.

Authors:  Helena Buch; Niels V Nielsen; Troels Vinding; Gorm B Jensen; Jan U Prause; Morten la Cour
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

10.  5-year incidence of age-related maculopathy in the Reykjavik Eye Study.

Authors:  Fridbert Jonasson; Arsaell Arnarsson; Tunde Peto; Hiroshi Sasaki; Kazuyuki Sasaki; Alan C Bird
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

View more
  5 in total

1.  Ultra-High Resolution Optical Coherence Tomography Imaging of Unilateral Drusen in a 31 Year Old Woman.

Authors:  Talisa E de Carlo; Mehreen Adhi; Chen D Lu; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Clin Med Rev Case Rep       Date:  2015-10-10

2.  Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.

Authors:  William Seiple; Danna Jennings; Richard B Rosen; Leona Borchert; Lee Canale; Nora Fagan; Mark Forrest Gordon
Journal:  Parkinsons Dis       Date:  2016-12-18

3.  The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats.

Authors:  Chengda Ren; Hui Shi; Juanjuan Jiang; Qingyu Liu; Yaru Du; Mengmei He; Wenting Cai; Qingquan Wei; Jing Yu
Journal:  J Ophthalmol       Date:  2017-10-22       Impact factor: 1.909

Review 4.  Drusen and pachydrusen: the definition, pathogenesis, and clinical significance.

Authors:  Xinyuan Zhang; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2020-11-18       Impact factor: 3.775

5.  Multimodal imaging of small hard retinal drusen in young healthy adults.

Authors:  Hilde R Pedersen; Stuart J Gilson; Alfredo Dubra; Inger Christine Munch; Michael Larsen; Rigmor C Baraas
Journal:  Br J Ophthalmol       Date:  2017-10-19       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.